Hisilicon: The application for issuing stocks to specific entities has been approved.

Hisen Pharmaceutical Group announced that on December 18, 2025, the company received a notice from the Listing Review Center of the Shenzhen Stock Exchange entitled "Notice of Opinion from the Listing Review Center on the Application of Hisen Pharmaceutical Group Limited to Issue Shares to Specific Objects". The Listing Review Center of the Shenzhen Stock Exchange has reviewed the company's application to issue shares to specific objects and believes that the company meets the issuance conditions, listing conditions, and disclosure requirements. The company's issuance of shares to specific objects still needs to be approved by the China Securities Regulatory Commission before it can be implemented.